Top Banner
Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT UN IC EF/Pirozzi
9

Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Jan 20, 2016

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Prevention of Mother to Child Transmission

Antiretroviral Drugs to Prevent MTCT

UNICEF/Pirozzi

Page 2: Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Presentation Objectives

By the end of the presentation you should be able to: 

•explain strategies for the prevention of MTCT;

•describe the different types of antiretroviral drugs for PMTCT.

Page 3: Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Types of ARVs

There are various types of ARV for the prevention of mother to child transmission including:– Nevirapine– Zidovudine

Short course prophylactic regimens of– zidovudine alone– zidovudine plus lamivudine– nevirapine alone intrapartum

Page 4: Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Choice of ARV Regimen

• Regimen should be determined by– Feasibility– Efficacy– Acceptability– Cost

• Nevirapine (single dose)– Demonstrated efficacy in clinical trials

(HIVNET 012 and SAINT)– Low cost and ease of use – Resistance?

Page 5: Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Lessons Learned and Future Challenges

Page 6: Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Lessons Learned and Recommendations

• Introducing ARV and/or replacement feeding options to reduce MTCT is a complex process

• Costs and benefits need to be carefully assessed• Strategy should be tailored to suit local

conditions– HIV prevalence rates – Risks of replacement feeding– The state of the existing health system and

MCH services – Maturity of the epidemic– Attitudes toward HIV in the community

Page 7: Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Integrated PMTCT Services

• PMTCT services are (or should be) integrated into Maternal and Child Health clinics.

• Implications:– Staff workload increases– ‘new’ skills are needed – Enhanced ANC for all women

Page 8: Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Issues to Consider when Planning MTCT Interventions

• Effective primary prevention programs and family planning services

• Adequate and functioning antenatal care programs

• Access to confidential VCT services• Follow-up care for mother and infant• Regulation and supply of ARV and

breastmilk substitutes

Page 9: Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

Future Challenges for PMTCT

• Ensuring that basic services are ready to integrate the new interventions

• Rising need for VCT services• Reorganization of pre-, peri-, and post-

natal care and family planning• Making decisions about infant feeding• Remaining questions about ART, infant

feeding, and MTCT• Care for orphans• Stigma and discrimination